News & Updates
Event Calendar
June 17, 2013 - 4:00pm
June 22, 2013 (All day)
Find A Specialist
Resource Finder at Kennedy Krieger Institute
Submitted by admin on June 23, 2011 - 3:08pm
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Biblio
Found 13 results
2011
Bolaños-Meade J, Smith DB, Gore SD, McDevitt MA, Luznik L, Fuchs EJ, Jones RJ.
2011. 5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):754-8. Abstract
2010
Luznik L, Jones RJ, Fuchs EJ.
2010. High-dose cyclophosphamide for graft-versus-host disease prevention.. Current opinion in hematology. 17(6):493-9. Abstract
Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith DB, Matsui WH, Goodman SN, Ambinder RF et al..
2010. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.. Blood. 115(11):2136-41. Abstract
Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith DB, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD et al..
2010. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.. Blood. 115(16):3224-30. Abstract
Symons HJ, Leffell SM, Rossiter ND, Zahurak M, Jones RJ, Fuchs EJ.
2010. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):533-42. Abstract
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolaños-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N et al..
2010. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):482-9. Abstract
2008
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell SM, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF et al..
2008. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(6):641-50. Abstract
2007
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R et al..
2007. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(10):1185-91. Abstract
2006
Huff CA, Fuchs EJ, Smith DB, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH et al..
2006. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 12(4):414-21. Abstract
2004
Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, Matsui WH, Arai S, Fuchs EJ, Vogelsang GB et al..
2004. Association of Foxp3 regulatory gene expression with graft-versus-host disease.. Blood. 104(7):2187-93. Abstract
2003
Huff CA, Fuchs EJ, Noga SJ, O'Donnell PV, Ambinder RF, Diehl L, Borrello I, Vogelsang GB, Miller CB, Flinn IA et al..
2003. Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 9(5):312-9. Abstract
Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, Amylon M, Sullivan KM, Storb RF, Walters MC.
2003. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 9(8):519-28. Abstract
2002
Smith DB, Jones RJ, Lee SM, Piantadosi S, Vala MS, Fuller D, Gore SD, Noga SJ, O'Donnell PV, Braine H et al..
2002. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.. British journal of haematology. 117(4):907-13. Abstract

